Recruiting

NEPHROCLEAR™ CCL14

Sponsor:

Astute Medical, Inc.

Code:

NCT04785391

Conditions

Acute Kidney Injury

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Urine collection for NEPHROCLEAR CCL14 Test

Study Details

Brief summary:

The objective of this sample collection study is to collect urine samples to validate the NEPHROCLEAR™ CCL14 Test in patients with KDIGO stage 2 or 3 AKI. This study is observational and will have no impact on the medical management of the subject.

Conditions

Acute Kidney Injury

Study ID

NCT04785391

Start date

Jun 8, 2021

Status verified date

Jul, 2022

Completion date

Dec, 2022

Anticipated

Primary completion date

Dec, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Males and females 21 years of age or older;
2. Receiving care in an intensive care unit;
3. Expected to remain in the ICU for at least 48 hours after enrollment;
4. Use of indwelling urinary catheter as standard care at the time of enrollment;
5. Subject must have acute kidney injury (KDIGO Stage 2 or Stage 3) at the time of sample collection;
6. Urine sample must be collected within 36 hours of meeting KDIGO Stage 2 criteria;
7. Written informed consent provided by patient or legally authorized representative (LAR).

Exclusion Criteria:

1. Prior kidney transplantation;
2. Comfort-measures-only status;
3. Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment;
4. Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic);
5. Special populations, pregnant women, prisoners or institutionalized individuals.

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients with KDIGO stage 2 or 3 AKI

Interventions

Urine collection for NEPHROCLEAR CCL14 Test

Urine will be collected and banked for future analysis with the NEPHROCLEAR CCL14 Test

Primary outcome measure

  • Persistent Severe Acute Kidney Injury as Determined by Physician Adjudication [ Time Frame: Within 5 days ]

Central Contacts and Locations

Central contacts

Locations

University of Pittsburgh Medical Center

Recruiting

Pittsburgh, Pennsylvania, United States, 15261

More Information

Sponsor

Astute Medical, Inc.

Last update posted

Jul 20, 2022

Last verified

Jul, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Astute Medical, Inc. on 2022-07-20.